The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

Department of Oncology, Cancer Research Campaign, Strangeways Research Laboratory, Cambridge, United Kingdom.
The American Journal of Human Genetics (Impact Factor: 10.99). 11/1999; 65(4):1021-9. DOI: 10.1086/302583
Source: PubMed

ABSTRACT To establish the contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer, we have analyzed both genes in DNA samples obtained from an affected individual in each of 112 families containing at least two cases of epithelial ovarian cancer. Germline mutations were found in 43% of the families; BRCA1 mutations were approximately four times more common than BRCA2 mutations. The extent of family history of ovarian and breast cancers was strongly predictive of BRCA1-mutation status. Segregation analysis suggests that a combination of chance clustering of sporadic cases and insensitivity of mutation detection may account for the remaining families; however, the contribution of other genes cannot be excluded. We discuss the implications for genetic testing and clinical management of familial ovarian cancer arising from the data presented in these studies.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background The aim of this study was to estimate the contribution of deleterious mutations in BRCA1, BRCA2, MLH1, MSH2, MSH6 and PMS2 to invasive epithelial ovarian cancer in the population.Methods The coding sequence and splice site boundaries of all six genes were amplified in germline DNA from 2,240 invasive EOC cases and 1,535 controls. Barcoded fragment libraries were sequenced using the Illumina GAII or HiSeq and sequence data for each subject de-multiplexed prior to interpretation. GATK and Annovar were used for variant detection and annotation. After quality control 2,222 cases (99.2 per cent) and 1,528 controls (99.5 per cent) were included in the final analysis.ResultsWe identified 193 EOC cases (8.7 per cent) carrying a deleterious mutation in at least one gene compared to 10 controls (0.65 per cent). Mutations were most frequent in BRCA1 and BRCA2, with 84 EOC cases (3.8 per cent) carrying a BRCA1 mutation and 94 EOC cases (4.2 per cent) carrying a BRCA2 mutation. The combined BRCA1 and BRCA2 mutation prevalence was 11 per cent in high-grade serous disease. Seventeen EOC cases carried a mutation in a mismatch repair gene, including 10 MSH6 mutation carriers (0.45 per cent) and 4 MSH2 mutation carriers (0.18 per cent).Conclusions At least one in ten women with high-grade serous EOC has a BRCA1 or BRCA2 mutation. The development of next generation sequencing technologies enables rapid mutation screening for multiple susceptibility genes at once, suggesting that routine clinical testing of all incidence cases should be considered.
    Human Molecular Genetics 04/2014; · 6.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The estimation of cancer risk in individuals is of great interest for research teams. The kin-cohort method is a method of choice for estimating hazards and penetrance of cancer, because of its capability to illustrate the correlation between genotype and phenotype. In the estimation of cancer penetrance, many models omit to take into account the fact that hazards are likely to increase, decrease, or remain constant with respect to age variations. In order to estimate cancer penetrance by rectifying the said drawback of the commonly used models , we utilized a modified piecewise exponential model using weibull distribution, i.e. a piecewise Weibull model. We considered mutations in BRCA1 and BRCA2 genes, which are related to ovarian and breast cancer. A set of data similar to true values was generated. We analyzed the data set using both piecewise exponential and piecewise Weibull models. Our results showed that the Weibull model was closer than the exponential model to the true values in terms of estimating the hazards and penetrance and a significant difference between two models was recognized. For the persons who are at risk of developing cancer, Due to the importance of the estimation of incidence probability, methods that can generate most accurate estimations are preferable. Therefore, we recommend the piecewise Weibull model as a proper model for the estimation of hazard and penetrance.
    World Applied Sciences Journal. 01/2009; 6(1):77-82.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ovarian cancer (OC) mostly arises sporadically, but a fraction of cases are associated with mutations in BRCA1 and BRCA2 genes. The presence of a BRCA mutation in OC patients has been suggested as a prognostic and predictive factor. In addition, the identification of asymptomatic carriers of such mutations offers an unprecedented opportunity for OC prevention. This review is aimed at exploring the current knowledge on epidemiological and molecular aspects of BRCA-associated OC predisposition, on pathology and clinical behavior of OC occurring in BRCA mutation carriers, and on the available options for managing asymptomatic carriers.
    BioMed Research International 01/2014; 2014:787143. · 2.71 Impact Factor


Available from